Literature DB >> 8527348

Alterations in sodium metabolism as an etiological model for hypertension.

P Lijnen1.   

Abstract

An adequate matching for race, sex, stage of the menstrual cycle, family history of hypertension, and the amount of sodium and other electrolytes in the diet should be a prerequisite for valid conclusions when interpreting the erythrocyte concentration and fluxes of sodium in essential hypertensive patients in comparison with normal subjects. Alterations in intracellular sodium concentration and transmembrane sodium transport systems as causes of essential hypertension are postulated. This review article describes how this abnormal sodium and calcium metabolism translates into increased systemic vascular resistance through altered vasoactive responses and/or vasculature structural changes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8527348     DOI: 10.1007/bf00879027

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  206 in total

1.  Plasma and erythrocyte sodium and potassium concentrations in a group of southern white and Negro blood donors.

Authors:  W D LOVE; G E BURCH
Journal:  J Lab Clin Med       Date:  1953-02

2.  Erythrocyte sodium and potassium transport systems during longterm administration of the diuretic xipamide in men.

Authors:  P Lijnen; A Amery
Journal:  Methods Find Exp Clin Pharmacol       Date:  1989-09

3.  Leukocyte intracellular cations in hypertension: Effect of antihypertensive drugs.

Authors:  M A Araoye; I M Khatri; L L Yao; E D Freis
Journal:  Am Heart J       Date:  1978-12       Impact factor: 4.749

4.  Dietary sodium, erythrocyte sodium concentration, sodium-stimulated lithium efflux and blood pressure.

Authors:  M Trevisan; R Cooper; D Ostrow; W Miller; S Sparks; Y Leonas; A Allen; M Steinhauer; J Stamler
Journal:  Clin Sci (Lond)       Date:  1981-12       Impact factor: 6.124

5.  Three red cell sodium transport systems in hypertensive and normotensive Utah adults.

Authors:  J B Smith; K O Ash; S C Hunt; W M Hentschel; W Sprowell; M M Dadone; R R Williams
Journal:  Hypertension       Date:  1984 Mar-Apr       Impact factor: 10.190

6.  Erythrocyte Na+,K+ cotransport and Na+,K+ pump in black and caucasian hypertensive patients.

Authors:  M L Tuck; C Gross; M H Maxwell; A S Brickman; G Krasnoshtein; D Mayes
Journal:  Hypertension       Date:  1984 Jul-Aug       Impact factor: 10.190

7.  Erythrocyte 22Na efflux and urinary sodium excretion in essential hypertension.

Authors:  W R Fitzgibbon; T O Morgan; J B Myers
Journal:  Clin Sci (Lond)       Date:  1980-12       Impact factor: 6.124

8.  A renal abnormality as a possible cause of "essential" hypertension.

Authors:  G Bianchi; D Cusi; M Gatti; G P Lupi; P Ferrari; C Barlassina; G B Picotti; G Bracchi; G Colombo; D Gori; O Velis; D Mazzei
Journal:  Lancet       Date:  1979-01-27       Impact factor: 79.321

Review 9.  Amiloride and its analogs as tools in the study of ion transport.

Authors:  T R Kleyman; E J Cragoe
Journal:  J Membr Biol       Date:  1988-10       Impact factor: 1.843

10.  Calcium-related abnormalities in lymphocytes from genetically hypertensive rats.

Authors:  P B Furspan; D F Bohr
Journal:  Hypertension       Date:  1986-06       Impact factor: 10.190

View more
  2 in total

Review 1.  Regulation of the Na+/K+-ATPase by insulin: why and how?

Authors:  G Sweeney; A Klip
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

2.  Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate.

Authors:  Cristina Menni; Delyth Graham; Gabi Kastenmüller; Nora H J Alharbi; Safaa Md Alsanosi; Martin McBride; Massimo Mangino; Philip Titcombe; So-Youn Shin; Maria Psatha; Thomas Geisendorfer; Anja Huber; Annette Peters; Rui Wang-Sattler; Tao Xu; Mary Julia Brosnan; Jeff Trimmer; Christian Reichel; Robert P Mohney; Nicole Soranzo; Mark H Edwards; Cyrus Cooper; Alistair C Church; Karsten Suhre; Christian Gieger; Anna F Dominiczak; Tim D Spector; Sandosh Padmanabhan; Ana M Valdes
Journal:  Hypertension       Date:  2015-06-01       Impact factor: 10.190

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.